Diltiazem administration in vivo also upregulated the serum level of GDF-15, as well as reduced EMT and MMP-9/MMP-2 expression, leading to a decrease in metastasis of breast cancer [115]. This evidence concerns the gene GDF15 and breast carcinoma.